3
Registered trials
0
Recruiting
3
Unique sponsors
2
Unique IMPs
3
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune)
1 substance
Unknown / small molecule
1 substance
Phase III:
1
Phase II:
1
Phase I (Other):
1
Phase III
1 trial-
PendingCelgene Corp. CommercialCC-97540
Phase II
1 trial-
EndedGenentech Inc. CommercialVIXARELIMAB
Phase I (Other)
1 trial-
PendingAntaros Medical AB CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Antaros Medical AB | Commercial | 1 | Phase I (Other) | 0 |
| Genentech Inc. | Commercial | 1 | Phase II | 0 |
| Celgene Corp. | Commercial | 1 | Phase III | 0 |
New trials by year
2023
1